Literature DB >> 23045471

Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) and cardiac fibroblast growth.

Xianwei Wang1, Magomed Khaidakov, Zufeng Ding, Sona Mitra, Jingjun Lu, Yao Dai, Jawahar L Mehta.   

Abstract

Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) regulates growth of a variety of cells and is important in inflammation, oxidative stress, and tissue remodeling. Recent studies show that LOX-1 deletion limits cardiac remodeling after sustained hypertension. We posited that LOX-1 may affect cardiac fibroblast growth and collagen secretion. To examine this postulate, we studied growth pattern of cardiac fibroblasts from hearts of wild-type and LOX-1 knockout (KO) mice. LOX-1 KO fibroblasts exhibited dramatically reduced growth when compared with wild-type mice fibroblasts and became much larger than wild-type mice fibroblasts in serial cultures, suggesting arrest of cell division. Western blotting and immunofluorescence showed that cell division control protein 42, a key regulator for cell division, was markedly downregulated in LOX-1 KO fibroblasts. The cytoskeletal organization in these fibroblasts was significantly altered in strand orientation, and some fibroblasts were completely devoid of F-actin. Furthermore, NADPH oxidase expression and generation of reactive oxygen species, as well as cell proliferation signals serine/threonine-specific protein kinase and murine double minute 2, were significantly reduced in LOX-1 KO fibroblasts. To confirm the essential role of LOX-1 in fibroblast growth, LOX-1 KO fibroblasts were transfected with h-LOX-1 cDNA. After transfection, the altered pattern of cytoskeletal organization, as well as expression of cell division control protein 42, serine/threonine-specific protein kinase, and murine double minute 2, was normalized. In congruent with these in vitro data, we found that the cardiac fibroblast number and expression of fibronectin and procoallagen-1/collagen were significantly lower in hypertensive LOX-1 KO mice hearts than in hypertensive wild-type mice hearts subjected to sustained hypertension (angiotensin II infusion). These findings implicate LOX-1 in cytoskeletal organization and growth of cardiac fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23045471     DOI: 10.1161/HYPERTENSIONAHA.112.200659

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  3 in total

1.  Atherogenic LOX-1 signaling is controlled by SPPL2-mediated intramembrane proteolysis.

Authors:  Torben Mentrup; Kosta Theodorou; Florencia Cabrera-Cabrera; Andreas O Helbig; Kathrin Happ; Marion Gijbels; Ann-Christine Gradtke; Björn Rabe; Akio Fukumori; Harald Steiner; Andreas Tholey; Regina Fluhrer; Marjo Donners; Bernd Schröder
Journal:  J Exp Med       Date:  2019-02-28       Impact factor: 14.307

2.  Structure-based Design Targeted at LOX-1, a Receptor for Oxidized Low-Density Lipoprotein.

Authors:  Shraddha Thakkar; Xianwei Wang; Magomed Khaidakov; Yao Dai; Kuppan Gokulan; Jawahar L Mehta; Kottayil I Varughese
Journal:  Sci Rep       Date:  2015-11-18       Impact factor: 4.379

3.  Profiling of circadian genes expressed in the uterus endometrial stromal cells of pregnant rats as revealed by DNA microarray coupled with RNA interference.

Authors:  Hirotaka Tasaki; Lijia Zhao; Keishiro Isayama; Huatao Chen; Seiichi Hashimoto; Masa-Aki Hattori
Journal:  Front Endocrinol (Lausanne)       Date:  2013-07-08       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.